• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠血液和中枢淋巴中邻碘马尿酸盐的药代动力学

Pharmacokinetics of ortho-I-hippurate in the blood and central lymph of the rat.

作者信息

Lamka J, Gallová S

机构信息

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University, Hradec Králové.

出版信息

Physiol Res. 1991;40(5):543-8.

PMID:1812982
Abstract

The authors studied ortho-I-hippurate kinetics in the blood and central lymph in two groups of intact rats and three groups of animals with induced pathological states (cirrhosis, uraemia, malabsorption). A differentiated lipid concentration in the central lymph was induced in intact animals by depriving them of food (the unfed group) or allowing them food (the fed group) before the experiment. All the hippurate kinetic parameters, including lymphatic bioavailability (FL), in the fed group were very close to those in the unfed group, which was also used as the control for the groups with induced pathological states. Cirrhosis, uraemia and malabsorption altered the blood and lymphatic kinetic parameters in many cases, but the changes mostly followed a parallel course so that FL was maintained (except in the uraemia group, in which it fell).

摘要

作者研究了两组完整大鼠以及三组诱导出病理状态(肝硬化、尿毒症、吸收不良)的动物的血液和中央淋巴中的邻碘马尿酸盐动力学。在实验前,通过不给完整动物喂食(未喂食组)或允许其进食(喂食组),在中央淋巴中诱导出不同的脂质浓度。喂食组中所有马尿酸盐动力学参数,包括淋巴生物利用度(FL),都与未喂食组非常接近,未喂食组也用作诱导病理状态组的对照。在许多情况下,肝硬化、尿毒症和吸收不良改变了血液和淋巴动力学参数,但变化大多呈平行趋势,因此FL得以维持(尿毒症组除外,该组FL下降)。

相似文献

1
Pharmacokinetics of ortho-I-hippurate in the blood and central lymph of the rat.大鼠血液和中枢淋巴中邻碘马尿酸盐的药代动力学
Physiol Res. 1991;40(5):543-8.
2
On the limiting factors affecting the distribution of model drugs from blood into the lymphatic system.关于影响模型药物从血液向淋巴系统分布的限制因素
Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:47-51.
3
Pharmacokinetics of inulin in blood and central lymph in the rat.菊粉在大鼠血液和中央淋巴中的药代动力学。
Pol J Pharmacol Pharm. 1992 Mar-Apr;44(2):147-52.
4
On pharmacokinetic evaluation of model drugs distribution into rat central lymph.模型药物在大鼠中枢淋巴中分布的药代动力学评价
Pol J Pharmacol Pharm. 1992 Jan-Feb;44(1):33-40.
5
Influence of the composition of rat central lymph on the pharmacokinetics (the steady state during infusion, bioavailability, absorption) of diazepam, studied in the blood and lymph.
Physiol Bohemoslov. 1990;39(5):403-8.
6
Differences in excretion of hippurate, as a metabolite of benzoate and as an administered species, in the single-pass isolated perfused rat kidney explained.解释了马尿酸作为苯甲酸的代谢产物以及作为给药物质在单通道离体灌注大鼠肾脏中的排泄差异。
J Pharmacol Exp Ther. 1999 Feb;288(2):597-606.
7
Intestinal absorption of tolfenamic acid at experimental malabsorption states in rats.大鼠实验性吸收不良状态下托芬那酸的肠道吸收情况
Arzneimittelforschung. 1981;31(12):2092-5.
8
The influence of experimentally induced pathological states on the flow and composition of central lymph in the rat.实验诱导的病理状态对大鼠中枢淋巴液流动和成分的影响。
Physiol Bohemoslov. 1986;35(4):328-33.
9
The pharmacokinetics of intraduodenally administered diazepam in rats as influenced by composition of the central lymph.十二指肠内给药的地西泮在大鼠体内的药代动力学受中央淋巴成分的影响
Physiol Bohemoslov. 1989;38(5):441-8.
10
Hippurate participation in the inhibition of glucose utilization in renal failure.马尿酸盐参与肾衰竭时葡萄糖利用的抑制过程。
Czech Med. 1987;10(2):79-89.